Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

The top 5 pharma firms by reputation

By Brian Buntz | April 12, 2021

Thumbs up

Photo by Anton on Unsplash

Recent research from reputation data specialist RepTrak (Boston) indicates that the pharma industry had the largest year-over-year reputational improvement of any sector, according to its roundup of top 100 corporations. The sector saw significant gains in consumers’ perception of its citizenship and governance. 

Now ranked eighth overall, the pharma industry came in just ahead of the consumer services industry and just behind the automobiles and components sector. 

The pharma industry began to see its reputation improve beginning in the second quarter of 2020, when the industry claimed a leading role in pandemic recovery, according to RepTrak.

In the Asia-Pacific region, the pharmaceutical sector has the highest reputation of any industry, according to RepTrak’s report. 

In creating the listing, RepTrack surveyed 68,577 people in 15 countries, asking them to assess established corporations’ reputation. The survey was conducted from December 2020 to January 2021. Only companies with revenues above $2 billion were eligible. 

RepTrak

RepTrak converted the survey results into numeric scores on a 100-point scale for each entrant. 

The top-ranking pharmaceutical firms in the ranking include the following corporations, listed in the order of their overall ranking in the 2021 Global RepTrak 100. 

Sanofi#64, Sanofi

Sanofi (Paris, France) moved up in the rankings this year in the Global RepTrak 100 listing. The company had a reputation score of 74.0. 

Sanofi has three core business units, including specialty care, vaccines and general medicines. It is spinning out a consumer health segment. 

#71, Novo Nordisk 


With a reputation score of 73.6, the diabetes specialist Novo Nordisk (Bagsværd, Denmark) cracked the top 10 among Boomers (aged 56 to 64), coming in at slot 8 for that demographic in the RepTrak ranking. Nevertheless, the company moved down in the rankings overall this year. 

#82, Eli Lilly 

Eli Lilly

Moving up in the rankings this year, Eli Lilly (Indianapolis, Ind.) develops drugs for depression, endocrinology, oncology and cardiovascular disease. Eli Lilly, named after the pharmaceutical chemist and Civil War veteran of the same name, had an overall reputational score of 73.3. 

#87, Roche 

With annual revenue of over $47 billion, Roche (Basel, Switzerland) is one of the world’s largest pharma companies. The pharmaceutical powerhouse had a reputational score of 73.2. The company moved down in the rankings this year. 

#94, Bristol-Myers Squibb

Bristol Myers Squibb
The New York City–headquartered pharmaceutical company has a broad focus, specializing in drug development related to cancer, HIV/AIDS, cardiovascular disease, diabetes, among other conditions. 

The company had an overall score of 73.1 in the rankings. It moved down in the rankings this year. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE